cerrar
Tagged with China

China Biosimilar Market Snapshot
Biosimilars are a relatively recent development in the pharmaceutical industry, meaning market penetration is still fairly low, even in many developed…

France’s Institut Pasteur Isolates Coronavirus; On Course to…
Researchers at the Institut Pasteur in Paris have become the first in Europe to fully sequence the genome of the 2019-nCoV coronavirus - putting the…

The Rise of Chinese Biosimilars
The Chinese healthcare market has transformed dramatically in the past few years. There have been many reforms centred around the country’s vision…

Yuguang Wang – CEO, Maxinovel Pharmaceuticals, China
Dr Yuguang Wang, CEO of Maxinovel Pharmaceuticals, recaps his three decades of industry experience across Big Pharma, biotech and CRO organizations in…

Chinese Biotechs Flock to IPO in Hong Kong
2019 was a bumper year for biotech companies listing on the Hong Kong Exchange (HKEx), with nine pre-revenue biotechs and eight revenue-generating…

Jens Ewert – Life Science and Health Care Industry Leader,…
Jens Ewert, Life Science and Health Care Industry Leader at Deloitte China, shares his perspectives on the growth of China’s Life Sciences and…

Hot Topics in Chinese Biotech
PharmaBoardroom sat down with more than 25 biotech CEOs in China in 2019. We analyzed the contents of the interviews and found the following recurring…

Company Spotlight: HiNounou – Gamifying Preventative in…
As patients and consumers grow more educated and proactive in managing their own health and wellbeing, new ventures are hoping to serve their needs in…

Key Highlights of China’s New Drug Administration Law
On 26 August 2019, the Chinese legislature, the National People’s Congress (NPC), passed the new Drug Administration Law (DAL), which came into…

Xiang Gao – Chairman, GemPharmatech, China
GemPharmatech is a fast-growing service center for production, distribution and phenotyping of gene-modified mouse models with multiple subsidiaries…

Most Looked at Countries in 2019
PharmaBoardroom had the opportunity to sit down with over six hundred key stakeholders in the life sciences industry across fifteen different…

Chinese Oncology Biotechs to Watch
Cancer is one of the world’s leading causes of death and in China, the globe’s most populous country, it is an ever-increasing concern. In 2018,…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here